申请人:SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
公开号:EP0725059A1
公开(公告)日:1996-08-07
A 2,3-diaminopropionic acid derivative represented by general formula (1) or a pharmaceutically acceptable salt thereof. This compound is useful as a platelet aggregation inhibitor, cancer metastasis inhibitor, wound remedy or bone resorption inhibitor.
由通式(1)代表的 2,3-二氨基丙酸衍生物或其药学上可接受的盐。该化合物可用作血小板聚集抑制剂、癌症转移抑制剂、伤口治疗剂或骨吸收抑制剂。